Related Experiment Video
Updated: Sep 20, 2025

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates
Published on: February 27, 2016
SIRT1: potential target in glucocorticoid-resistant diseases
Jun Xie1, Siyi Che1, Jiao Liu1
1Department of Respiratory Medicine, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders; Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China.
Glucocorticoid resistance is a clinical challenge. The review highlights how SIRT1 regulates glucocorticoid signaling, suggesting SIRT1 as a potential therapeutic target to improve treatment outcomes for glucocorticoid-resistant diseases.
Area of Science:
- Molecular Biology
- Cellular Biology
- Endocrinology
Background:
- Glucocorticoid resistance poses significant clinical challenges, particularly in inflammatory diseases.
- Reduced glucocorticoid receptor (GR) expression and impaired nuclear translocation are key factors in steroid resistance.
- Histone deacetylase SIRT1 influences steroid hormone receptor activity and is implicated in glucocorticoid resistance.
Purpose of the Study:
- To review the role of SIRT1 in regulating glucocorticoid signaling pathways.
- To explore the association between SIRT1 and the glucocorticoid receptor (GR).
- To examine the involvement of SIRT1 in common glucocorticoid-resistant diseases.
Main Methods:
- Literature review of recent advances in SIRT1 and glucocorticoid signaling.
- Description of SIRT1 structure, expression, and localization.
- Analysis of molecular mechanisms linking SIRT1 to GR activity and disease.
Main Results:
- SIRT1 regulates glucocorticoid activity and interacts with the GR.
- Reduced SIRT1 expression is observed in certain glucocorticoid-resistant conditions.
- SIRT1 plays a role in the mechanisms of various glucocorticoid-resistant diseases.
Conclusions:
- SIRT1 is a key regulator of glucocorticoid signaling.
- Modulating SIRT1 activity offers a potential therapeutic strategy for glucocorticoid-resistant diseases.
- Targeting SIRT1 presents a promising avenue for improving patient treatment outcomes.
More Related Videos
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

